Jones Hill Capital »

Pharvaris N V shares owned by Jones Hill Capital

Quarter-by-quarter ownership of Pharvaris N V (PHVS) shares owned by Jones Hill Capital from 13F filings

Historical chart of Jones Hill Capital investment in Pharvaris N V

Tip: Access up to 7 years of quarterly data

All positions including Pharvaris N V held by Jones Hill Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharvaris N V by Jones Hill Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $23M 678k 34.58
2026-03-31 $4.7M 167k 28.25

More positions owned by Jones Hill Capital

BioMarin Pharmaceutical (BMRN)
Gilead Sciences (GILD)
Arcutis Biotherapeutics (ARQT)
Madrigal Pharmaceuticals (MDGL)
Bicara Therapeutics (BCAX)
Relmada Therapeutics (RLMD)
Trevi Therapeutics (TRVI)
Pharvaris N V (PHVS)
Xenon Pharmaceuticals (XENE)
Biosante Pharmaceuticals (ANIP)
Immunocore Hldgs Ads (IMCR)
Amylyx Pharmaceuticals (AMLX)
Insmed Com Par $.01 (INSM)
Nuvalent Inc-a (NUVL)
Capricor Therapeutics Com New (CAPR)

View all positions for Jones Hill Capital

Top funds holding Pharvaris N V

FMR
General Atlantic
Foresite Capital Management IV
venBio Partners
Viking Global Investors
EQT Fund Management S.a r.l.
Deerfield Management Company
Bain Capital Life Sciences Investors
Wellington Management Company
Polar Capital Holdings
Point72 Asset Management
Commodore Capital
Novo A/S
Saturn V Capital Management
TCG Crossover Management

View all funds holding Pharvaris N V